1. Home
  2. BRW vs MGTX Comparison

BRW vs MGTX Comparison

Compare BRW & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRW
  • MGTX
  • Stock Information
  • Founded
  • BRW 1987
  • MGTX 2015
  • Country
  • BRW United States
  • MGTX United States
  • Employees
  • BRW N/A
  • MGTX N/A
  • Industry
  • BRW Trusts Except Educational Religious and Charitable
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BRW Finance
  • MGTX Health Care
  • Exchange
  • BRW Nasdaq
  • MGTX Nasdaq
  • Market Cap
  • BRW 308.8M
  • MGTX 282.3M
  • IPO Year
  • BRW N/A
  • MGTX N/A
  • Fundamental
  • Price
  • BRW $7.34
  • MGTX $4.42
  • Analyst Decision
  • BRW
  • MGTX Strong Buy
  • Analyst Count
  • BRW 0
  • MGTX 2
  • Target Price
  • BRW N/A
  • MGTX $26.00
  • AVG Volume (30 Days)
  • BRW 222.1K
  • MGTX 218.3K
  • Earning Date
  • BRW 01-01-0001
  • MGTX 08-08-2024
  • Dividend Yield
  • BRW 15.59%
  • MGTX N/A
  • EPS Growth
  • BRW N/A
  • MGTX N/A
  • EPS
  • BRW N/A
  • MGTX N/A
  • Revenue
  • BRW N/A
  • MGTX $697,000.00
  • Revenue This Year
  • BRW N/A
  • MGTX N/A
  • Revenue Next Year
  • BRW N/A
  • MGTX $447.29
  • P/E Ratio
  • BRW N/A
  • MGTX N/A
  • Revenue Growth
  • BRW N/A
  • MGTX N/A
  • 52 Week Low
  • BRW $7.15
  • MGTX $3.49
  • 52 Week High
  • BRW $8.30
  • MGTX $7.60
  • Technical
  • Relative Strength Index (RSI)
  • BRW 65.90
  • MGTX 47.28
  • Support Level
  • BRW $6.86
  • MGTX $4.55
  • Resistance Level
  • BRW $7.15
  • MGTX $5.12
  • Average True Range (ATR)
  • BRW 0.11
  • MGTX 0.26
  • MACD
  • BRW 0.04
  • MGTX 0.08
  • Stochastic Oscillator
  • BRW 97.78
  • MGTX 43.44

About BRW Saba Capital Income & Opportunities Fund SBI

Saba Capital Income & Opportunities Fund t is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Share on Social Networks: